Vascular Medicine Twitter Journal Club
Journal Club Articles
Vascular Medicine hosts a journal club twice yearly in the Spring and Fall. The journal club is facilitated by Social Media Editor Dr. Alec Schmaier. The articles are selected by Dr. Schmaier and Dr. Heather Gornik (Editor in Chief). All are welcome to attend. The discussion takes place on Twitter using the hashtag, #VascMedJC.
Tips and Reminders:
- To participate in the journal club, click on @VMJ_SVM or search for #VascMedJC on Twitter.
- Include the hashtag #VascMedJC on all tweets to ensure they are seen by all participants.
- When responding to a tweet, choose retweet with comment/quote tweet (don’t just directly reply).
The journal club schedule and details are presented in the table below.
If you have any questions, please contact the editorial office.
Journal Club Date | Journal Club Materials |
---|---|
11/15/2022, 8:00 p.m. – 9:00 p.m. EST |
Download agenda and discussion items Improvement in walking impairment following surgical and endovascular revascularization: Insights from VOYAGER PAD
|
4/12/2022, 8:00 p.m. EST |
Download agenda and discussion items. An estimate of the economic burden of venous leg ulcers associated with deep venous disease
|
10/26/2021, 8:00 p.m. EST |
Download agenda and discussion items. Optimization of duplex velocity criteria for diagnosis of internal carotid artery (ICA) stenosis: A report of the Intersocietal Accreditation Commission (IAC) Vascular Testing Division Carotid Diagnostic Criteria Committee |
3/15/2020, 8:00 p.m. EST |
Download agenda and discussion items. 2021 ACC/AHA/SVM/ACP Advanced Training Statement on Vascular Medicine (Revision of the 2004 ACC/ACP/SCAI/SVMB/SVS Clinical Competence Statement on Vascular Medicine and Catheter-Based Peripheral Vascular Interventions) |
9/15/2020 |
Download agenda and discussion questions Outcomes of catheter-directed versus systemic thrombolysis for the treatment of pulmonary embolism: A real-world analysis of national administrative claims |
3/3/2020 |
Download agenda and discussion questions Net clinical benefit of anticoagulation for atrial fibrillation following intracerebral hemorrhage The conundrum of resuming anticoagulant therapy after intracerebral bleeding: in whom, when, and how? |
9/18/2019 |
Download agenda and discussion questions Chronic kidney disease and risk for cardiovascular and limb outcomes in patients with symptomatic peripheral artery disease: The EUCLID trial |